In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

L. M. 'T Hart; A. Fritsche; G. Nijpels; N. Van Leeuwen; L. A. Donnelly; J. M. Dekker; M. Alssema; J. Fadista; F. Carlotti; A. P. Gjesing; C. N. Palmer; T. W. Van Haeften; S. A. Herzberg-Schäfer; A. M. Simonis-Bik; J. J. Houwing-Duistermaat; Q. Helmer; J. Deelen; B. Guigas; T. Hansen; F. MacHicao; G. Willemsen; R. J. Heine; M. H. Kramer; J. J. Holst; E. J. De Koning; H. U. Häring; O. Pedersen; L. Groop; E. J. De Geus; P. E. Slagboom; D. I. Boomsma; E. M. Eekhoff; E. R. Pearson; M. Diamant

doi:https://doi.org/10.1089/dia.2015.1514

In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

L. M. 'T Hart, A. Fritsche, G. Nijpels, N. Van Leeuwen, L. A. Donnelly, J. M. Dekker, M. Alssema, J. Fadista, F. Carlotti, A. P. Gjesing, C. N. Palmer, T. W. Van Haeften, S. A. Herzberg-Schäfer, A. M. Simonis-Bik, J. J. Houwing-Duistermaat, Q. Helmer, J. Deelen, B. Guigas, T. Hansen, F. MacHicaoG. Willemsen, R. J. Heine, M. H. Kramer, J. J. Holst, E. J. De Koning, H. U. Häring, O. Pedersen, L. Groop, E. J. De Geus, P. E. Slagboom, D. I. Boomsma, E. M. Eekhoff, E. R. Pearson, M. Diamant

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	S131-S133
Journal	Diabetes Technology and Therapeutics
Volume	17
DOIs	https://doi.org/10.1089/dia.2015.1514
Publication status	Published - 1 Feb 2015

Access to Document

https://doi.org/10.1089/dia.2015.1514

Cite this

'T Hart, L. M., Fritsche, A., Nijpels, G., Van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N., Van Haeften, T. W., Herzberg-Schäfer, S. A., Simonis-Bik, A. M., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., ... Diamant, M. (2015). In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus. Diabetes Technology and Therapeutics, 17, S131-S133. https://doi.org/10.1089/dia.2015.1514

@article{91eabdf38cf04096888644ade028af23,

title = "In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus",

author = "{'T Hart}, {L. M.} and A. Fritsche and G. Nijpels and {Van Leeuwen}, N. and Donnelly, {L. A.} and Dekker, {J. M.} and M. Alssema and J. Fadista and F. Carlotti and Gjesing, {A. P.} and Palmer, {C. N.} and {Van Haeften}, {T. W.} and Herzberg-Sch{\"a}fer, {S. A.} and Simonis-Bik, {A. M.} and Houwing-Duistermaat, {J. J.} and Q. Helmer and J. Deelen and B. Guigas and T. Hansen and F. MacHicao and G. Willemsen and Heine, {R. J.} and Kramer, {M. H.} and Holst, {J. J.} and {De Koning}, {E. J.} and H{\"a}ring, {H. U.} and O. Pedersen and L. Groop and {De Geus}, {E. J.} and Slagboom, {P. E.} and Boomsma, {D. I.} and Eekhoff, {E. M.} and Pearson, {E. R.} and M. Diamant",

year = "2015",

month = feb,

day = "1",

doi = "https://doi.org/10.1089/dia.2015.1514",

language = "English",

volume = "17",

pages = "S131--S133",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

}

'T Hart, LM, Fritsche, A, Nijpels, G, Van Leeuwen, N, Donnelly, LA, Dekker, JM, Alssema, M, Fadista, J, Carlotti, F, Gjesing, AP, Palmer, CN, Van Haeften, TW, Herzberg-Schäfer, SA, Simonis-Bik, AM, Houwing-Duistermaat, JJ, Helmer, Q, Deelen, J, Guigas, B, Hansen, T, MacHicao, F, Willemsen, G, Heine, RJ, Kramer, MH, Holst, JJ, De Koning, EJ, Häring, HU, Pedersen, O, Groop, L, De Geus, EJ, Slagboom, PE, Boomsma, DI, Eekhoff, EM, Pearson, ER & Diamant, M 2015, 'In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus', Diabetes Technology and Therapeutics, vol. 17, pp. S131-S133. https://doi.org/10.1089/dia.2015.1514

TY - JOUR

T1 - In vivo efficacy of HD0471953

T2 - A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

AU - 'T Hart, L. M.

AU - Fritsche, A.

AU - Nijpels, G.

AU - Van Leeuwen, N.

AU - Donnelly, L. A.

AU - Dekker, J. M.

AU - Alssema, M.

AU - Fadista, J.

AU - Carlotti, F.

AU - Gjesing, A. P.

AU - Palmer, C. N.

AU - Van Haeften, T. W.

AU - Herzberg-Schäfer, S. A.

AU - Simonis-Bik, A. M.

AU - Houwing-Duistermaat, J. J.

AU - Helmer, Q.

AU - Deelen, J.

AU - Guigas, B.

AU - Hansen, T.

AU - MacHicao, F.

AU - Willemsen, G.

AU - Heine, R. J.

AU - Kramer, M. H.

AU - Holst, J. J.

AU - De Koning, E. J.

AU - Häring, H. U.

AU - Pedersen, O.

AU - Groop, L.

AU - De Geus, E. J.

AU - Slagboom, P. E.

AU - Boomsma, D. I.

AU - Eekhoff, E. M.

AU - Pearson, E. R.

AU - Diamant, M.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923101546&partnerID=8YFLogxK

U2 - https://doi.org/10.1089/dia.2015.1514

DO - https://doi.org/10.1089/dia.2015.1514

M3 - Comment/Letter to the editor

SN - 1520-9156

VL - 17

SP - S131-S133

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

Access to Document

Other files and links

Cite this